TS Financial Group (TSFG)’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17K Hold
178
﹤0.01% 525
2026
Q1
$16K Hold
178
﹤0.01% 501
2025
Q4
$17K Hold
178
﹤0.01% 484
2025
Q3
$18K Hold
178
﹤0.01% 487
2025
Q2
$19K Hold
178
﹤0.01% 461
2025
Q1
$16K Hold
178
﹤0.01% 475
2024
Q4
$20K Hold
178
﹤0.01% 395
2024
Q3
$21K Hold
178
﹤0.01% 392
2024
Q2
$14K Hold
178
﹤0.01% 428
2024
Q1
$16K Hold
178
﹤0.01% 411
2023
Q4
$19K Hold
178
0.01% 398
2023
Q3
$19K Hold
178
0.01% 417
2023
Q2
$19K Hold
178
0.01% 419
2023
Q1
$22K Hold
178
0.01% 393
2022
Q4
$27K Hold
178
0.01% 366
2022
Q3
$24K Sell
178
-80
-31% -$12.2K 0.01% 377
2022
Q2
$38K Hold
258
0.02% 317
2022
Q1
$44K Sell
258
-38
-13% -$6.38K 0.02% 314
2021
Q4
$76K Sell
296
-22
-7% -$6.03K 0.03% 257
2021
Q3
$87K Hold
318
0.03% 235
2021
Q2
$71K Hold
318
0.03% 267
2021
Q1
$35K Hold
318
0.02% 300
2020
Q4
$26K Buy
318
+80
+34% +$7.85K 0.01% 335
2020
Q3
$16K Buy
238
+200
+526% +$14.3K 0.01% 357
2020
Q2
$3K Buy
+38
New +$1.9K ﹤0.01% 580

Other funds holding BNTX

TS Financial Group (TSFG)'s BNTX Position: Q2 2026 in Review

TS Financial Group (TSFG) held its BioNTech (BNTX) position steady in Q2 2026 at 178 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

TS Financial Group (TSFG) first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $87K in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • TS Financial Group (TSFG) held 178 shares of BioNTech worth $17K as of Q2 2026.
  • TS Financial Group (TSFG) left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #525 holding.
  • TS Financial Group (TSFG) first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • TS Financial Group (TSFG)'s BioNTech position peaked at $87K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.